Metpath GP 1mg/500mg/7.5mg Tablet SR
Marketer
Proqol Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Metpath GP 1mg/500mg/7.5mg Tablet SR
DiabeTol SR tablets (1mg/500mg/7.5mg) combine medications to manage blood glucose. Used alongside diet and exercise, it improves blood sugar control in adults with type 2 diabetes by enhancing insulin effectiveness. Dosage and frequency should strictly follow your doctor's instructions. Take with food to minimize stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double up. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your physician of any kidney, liver, or heart issues before starting. Pregnant or breastfeeding individuals should consult their doctor. Kidney function will be assessed prior to treatment. Limit alcohol consumption to reduce potential side effects.
Uses of Metpath GP 1mg/500mg/7.5mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Metpath GP 1mg/500mg/7.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metpath GP 1mg/500mg/7.5mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this extended-release tablet with a meal.
Common Side effects of Metpath GP 1mg/500mg/7.5mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metpath GP 1mg/500mg/7.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metpath GP 1mg/500mg/7.5mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.
How Metpath GP 1mg/500mg/7.5mg Tablet SR works:
Metpath GP SR tablets (1mg/500mg/7.5mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—for enhanced blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and boosting insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Metpath GP 1mg/500mg/7.5mg SR tablets is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Metpath GP 1mg/500mg/7.5mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metpath GP tablets (1mg/500mg/7.5mg) are likely not safe for use while breastfeeding. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Metpath GP 1mg/500mg/7.5mg SR tablets, as dosage modification may be necessary. Severe kidney disease contraindicates the use of Metpath GP 1mg/500mg/7.5mg SR tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Metpath GP 1mg/500mg/7.5mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Metpath GP 1mg/500mg/7.5mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metpath GP 1mg/500mg/7.5mg Tablet SR :
Should you forget to take your Metpath GP 1mg/500mg/7.5mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Metpath GP 1mg/500mg/7.5mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently